Meghan FitzGerald - 20 Apr 2023 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role: Director
Signature: By: /s/ Jo Chen, as Attorney-in-Fact for Meghan FitzGerald
Issuer symbol: ROIV
Transactions as of: 20 Apr 2023
Net transactions value: $0
Form type: 4
Filing time: 24 Apr 2023, 21:28:24 UTC
Previous filing: 16 Mar 2023
Next filing: 23 Jun 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ROIV	Stock Option (Right to Buy)	Award	$0	+118,578		$0.000000	118,578	20 Apr 2023	Common Shares	118,578	$8.80	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Award of stock options to purchase Common Shares with a vesting commencement date of March 13, 2023. These options vest and become exercisable (i) 1/3 on the first anniversary of the vesting commencement date and (ii) in twenty-four (24) successive equal monthly installments measured from the first anniversary of the vesting commencement date, subject to the reporting person's continuous service through the applicable vesting date.

Content

Award of stock options to purchase Common Shares with a vesting commencement date of March 13, 2023. These options vest and become exercisable (i) 1/3 on the first anniversary of the vesting commencement date and (ii) in twenty-four (24) successive equal monthly installments measured from the first anniversary of the vesting commencement date, subject to the reporting person's continuous service through the applicable vesting date.